• Anesthesia and Analgesia in Laboratory Animals focuses on the special anesthetic, analgesic and postoperative care requirements associated with experimental interventions. Fully revised and updated, this new edition provides the reader with agents, methods and techniques for anesthesia and analgesia that ensure humane, reproducible, and successful procedural outcomes. Sections cover ethical, regulatory and scientific considerations, principles of anesthesia and analgesia, anesthetic equipment and monitoring, periprocedural care, including dedicated chapters to the assessment and management of pain in laboratory species, and practical considerations by species, including relevant anatomy, physiology, and behavior of a broad range of lab animal species.

    This will be a complete reference for veterinarians involved in lab animal research as well as senior graduate, graduate students, post-docs and researchers who utilize animals in biomedical research.

    Key features

    • Provides researchers with the most comprehensive and up-to-date review of the use of anesthesia and analgesia in laboratory animals
    • Includes complete coverage of agents' impact in research outcomes
    • Thoroughly updated with new material on ferrets, birds, reptiles, amphibians, fish and cephalopods
    • Covers hot topic areas such as pain research, ethical issues, legal issues and imaging studies
    • Cover image

    • Title page

    • Table of Contents

    • American College of Laboratory Animal Medicine Series

    • Copyright

    • Contributors

    • Preface

    • Abbreviations

    • Section I. Ethical, regulatory, and scientific considerations

    • Chapter 1. Ethics

    • I. Introduction

    • II. Consequentialist ethics in laboratory animal use

    • III. Minimizing harms and maximizing pleasures for animals in laboratories

    • IV. The Three Rs approach to minimizing harms to animals

    • V. Justifying harms to animals, beyond the Three Rs

    • VI. Veterinarians as anesthesia and analgesia experts and advocates: responsibilities and authority

    • VII. Significant unalleviated pain and distress (Category E experiments)

    • VIII. Ethics of uncertainty

    • IX. Critical anthropomorphism

    • X. Conclusion

    • Chapter 2. Regulatory issues

    • I. Introduction

    • II. Regulations, standards, and policies on humane animal care in the United States

    • III. Drug enforcement regulations and policies

    • IV. Occupational health and safety considerations

    • V. International considerations

    • Chapter 3. Optimizing anesthesia and analgesia for specific research projects

    • I. General implications of anesthesia and analgesia on study design

    • II. Specific implications of anesthesia and analgesia on study design

    • III. Conclusions

    • Section II. Principles of anesthesia and analgesia

    • Chapter 4. Injectable anesthetics

    • I. Introduction

    • II. γ-aminobutyric acid receptor agonists

    • III. NMDA-antagonists

    • IV. Miscellaneous agents

    • V. Anesthetic combinations

    • VI. Injectable anesthetic delivery systems

    • Chapter 5. Tranquilizers, sedatives, local anaesthetics and antimuscarinic agents

    • I. Tranquilizers and sedatives

    • II. Local anesthetics

    • III. Muscarinic antagonists

    • IV. Conclusion

    • Chapter 6. Inhalant anesthetics and safety

    • I. Veterinary pharmacology of inhalation anesthetics

    • II. Single circuit and multi circuit design

    • III. Vaporizers

    • IV. Anesthesia machines and workstations

    • V. Induction chambers

    • VI. Choosing inhalants for research

    • VII. Waste anesthetic gas

    • VIII. Summary and conclusions of waste anesthetic gas

    • Chapter 7. Pharmacology of Analgesics

    • I. Introduction

    • II. Nonsteroidal anti-inflammatory drugs

    • III. Opioids

    • IV. α2-adrenergic agonists

    • V. N-methyl-D-aspartate receptor antagonists

    • VI. Gabapentinoids

    • VII. Future prospects

    • Chapter 8. Neuromuscular blocking agents

    • I. Introduction

    • II. Indications for use of neuromuscular blocking agents

    • III. Contraindications for use of NMBA

    • IV. Welfare implications of using neuromuscular blocking agents

    • V. Neuromuscular junction anatomy and physiology

    • VI. Mechanism of action of NMBA

    • VII. Clinical use and monitoring

    • VIII. Monitoring of neuromuscular function

    • IX. Clinical pharmacology and use of reversal agents

    • X. Future and upcoming agents

    • Section III. Anesthetic equipment and monitoring

    • Chapter 9. Anesthesia delivery systems

    • I. Introduction

    • II. Anesthesia machine

    • III. Patient interface

    • Chapter 10. Monitoring of anesthesia

    • I. Introduction

    • II. Monitoring of the anesthetized patient

    • III. Special circumstances

    • IV. Summary and conclusions

    • Section IV. Periprocedural care

    • Chapter 11. General care: periprocedural management considerations for research animals

    • I. Introduction

    • II. Oversight, planning, and organization

    • III. Medical recordkeeping and veterinary care

    • IV. Interventions for care and well-being

    • V. Humane endpoint considerations

    • Chapter 12. Pain assessment in laboratory species

    • I. Introduction

    • II. Types of pain

    • III. Why prevent pain?

    • IV. Pain assessment

    • V. Pain assessment methods

    • VI. Challenges in assessment of pain

    • VII. Documentation and record-keeping

    • VIII. Summary

    • Chapter 13. Basic considerations for pain management in laboratory animals

    • I. Rationale for pain mitigation

    • II. Considerations for prescription of analgesia

    • III. Nonpharmacological treatments for pain

    • IV. Operational aspects of pain management

    • Section V. Practical considerations by species

    • Chapter 14. Anesthesia and analgesia in laboratory rodents

    • I. Introduction

    • II. Pre-procedural considerations

    • III. Anesthesia

    • IV. Historic anesthetic regimens used for special purposes

    • V. Use of neuromuscular blocking agents and antagonists

    • VI. Anesthesia for specific situations

    • VII. Post-procedural recovery and care

    • VIII. Analgesia

    • Chapter 15. Anesthesia and analgesia in rabbits

    • I. Introduction

    • II. Preoperative considerations

    • III. Anesthesia

    • IV. Anesthetic circuits, monitoring and support

    • V. Postoperative analgesia

    • Chapter 16. Anesthesia, restraint and analgesia in laboratory fishes

    • I. Introduction

    • II. Preprocedural considerations

    • III. Restraint

    • IV. Analgesia, anesthesia and balanced anesthesia

    • V. Postprocedural recovery and care

    • VI. Pain and welfare assessment

    • Chapter 17. Anesthesia and analgesia in laboratory pigs

    • I. Introduction

    • II. Preprocedural considerations and planning

    • III. Sedation

    • IV. General anesthesia

    • V. Animal preparation

    • VI. Anesthetic monitoring and support

    • VII. Common anesthetic emergencies

    • VIII. Postprocedural recovery and care

    • IX. Analgesia

    • Chapter 18. Anesthesia and analgesia in nonhuman primates

    • I. Introduction

    • II. Preprocedural considerations

    • III. Chemical restraint

    • IV. Anesthesia

    • V. Analgesia

    • VI. Special considerations

    • VII. Responding to emergencies

    • VIII. Postprocedural recovery and care

    • Chapter 19. Anesthesia and analgesia in dogs and cats

    • I. Introduction

    • II. Preprocedural considerations

    • III. Chemical restraint (sedation)

    • IV. General anesthesia

    • V. Anesthetic management and monitoring

    • VI. Common anesthetic emergencies

    • VII. Anesthesia for specific situations

    • VIII. Postprocedural recovery and care

    • IX. Pain assessment and analgesia

    • Chapter 20. Anesthesia and analgesia in ruminants

    • I. Introduction

    • II. Preprocedural considerations

    • III. Pain assessment and the need for analgesia

    • IV. Sedation and premedication

    • V. Anesthesia

    • VI. Maintenance of anesthesia

    • VII. Anesthesia monitoring

    • VIII. Intraoperative support

    • IX. Analgesia

    • Chapter 21. Analgesia and anesthesia in ferrets

    • I. Introduction

    • II. Preprocedural considerations

    • III. Chemical restraint (sedation) principles

    • IV. General anesthesia principles

    • V. Support and monitoring of the patient

    • VI. Drugs used for sedation and anesthesia

    • VII. Common anesthetic emergencies and treatment

    • VIII. Postanesthetic considerations

    • IX. Analgesia

    • X. Anesthesia and analgesia for specific situations

    • Chapter 22. Anesthesia and analgesia in other mammals

    • I. Marsupialia: marsupials

    • II. Scandentia and Eulipotyphla: insectivores

    • III. Rodentia: nontraditional species of laboratory rodents

    • V. Xenarthra: edentates (nine-banded armadillo—Dasypus novemcinctus)

    • VI. Chiroptera: bats

    • VIII. Prosimii: gray mouse lemur (Microcebus murinus)

    • Chapter 23. Anesthesia and analgesia in birds

    • I. Avian physiology and anatomy relevant to anesthesia and analgesia

    • II. Preprocedural considerations

    • III. Preoperative management

    • IV. Anesthetic agents

    • V. Anesthetic monitoring, management and emergencies

    • VI. Anesthetic recovery

    • VII. Analgesia

    • VIII. Anesthesia for specific situations

    • Chapter 24. Anesthesia and analgesia in reptiles

    • I. Introduction

    • II. Reptilian anatomy and physiology of anesthetic and analgesic relevance

    • III. Preprocedural considerations

    • IV. Chemical restraint versus anesthesia

    • V. Anesthesia

    • VI. Anesthesia for specific situations

    • VII. Postanesthetic recovery and care

    • VIII. Analgesia

    • IX. Euthanasia

    • Chapter 25. Anesthesia and analgesia in amphibians

    • I. Introduction

    • II. Anatomy and physiology relevant to anesthesia

    • III. Preprocedural considerations

    • IV. Chemical restraint versus anesthesia

    • V. Chemical restraint

    • VI. Monitoring

    • VII. Analgesia

    • VIII. Anesthesia and analgesia for specific situations

    • IX. Postprocedural recovery and care

    • X. Euthanasia

    • Chapter 26. Anesthesia and analgesia in invertebrates

    • I. Introduction

    • II. Anesthesia

    • III. Pain and analgesia in invertebrates

    • IV. Euthanasia

    • Section VI. Special topics

    • Chapter 27. Management of chronic pain

    • I. Introduction

    • II. Recognition and assessment of chronic pain

    • III. Treatment

    • Chapter 28. Anesthesia and analgesia in the fetus and neonate

    • I. Introduction

    • II. Anesthesia of the dam for fetal surgery

    • III. Neuraxial analgesia/anesthesia

    • IV. Prevention of post-operative pre-term labor

    • V. Functional maturity of key organ systems in newborn animals

    • VI. Anesthesia of neonatal animals

    • VII. Supportive measures during neonatal anesthesia

    • VIII. Postanesthetic period

    • IX. Neonatal analgesia

    • Chapter 29. Anesthesia for in vivo imaging studies: practical considerations for experimental outcomes and animal welfare

    • I. Introduction

    • II. Imaging modalities

    • III. Animal preparation and experimental planning

    • IV. Management of anesthesia in imaging studies

    • V. Conclusions

    • Chapter 30. Preclinical pain testing: a short guide to where we are and where we are going

    • I. Why the need for animal use in pain research?

    • II. Animal models (assays) of pain

    • III. Pain measures

    • IV. Organismic and environmental factors

    • V. External and internal validity

    • VI. The future of preclinical pain research

    • Index

  • Melissa Dyson

    Melissa Dyson, DVM, MS, DACLAM is the University of Michigan's Senior Associate Attending Veterinarian, the Deputy Director of the Unit for Laboratory Animal Medicine (ULAM), and the Director of the ULAM Training Core. In her role as Senior Associate Attending Veterinarian, Dr. Dyson assists with the guidance and oversight of the Animal Care & Use Program, including the exploration of new data-gathering and assessment strategies that support a culture of responsible research conduct. As the Deputy Director of ULAM, she assists in the overall management of the Unit, including animal husbandry, housing, veterinary care, and specialized research support services. Dr. Dyson also serves as the Director of the ULAM Training Core, where she is responsible for managing all animal care and use training and education programs at the University. Dr. Dyson's clinical and research interests include laboratory animal medicine management and infectious disease. She is also interested in training research personnel in the humane use and handling of animals used for research, as well as the training of future laboratory animal scientists and clinicians.

    Affiliations and expertise

    University of Michigan's Senior Associate Attending Veterinarian, Deputy Director, Unit for Laboratory Animal Medicine (ULAM); Director of the ULAM Training Core, USA

    Paulin Jirkof

    Studied biology with a focus on zoology. She obtained her PhD in Neuroscience at the Institute for Laboratory Animal Science, University of Zurich, Switzerland. She has been certified as an expert for laboratory animal science by the German Association for Laboratory Animal Science (GV SOLAS). Currently, she holds a position as 3R coordinator at the University of Zurich, Switzerland. She is chair of the Executive Board of The Swiss 3R Competence Center (3RCC), board member of the Swiss Association of Laboratory Animal Science (SGV), member of the Scientific Advisory Board of Charitè 3R, Berlin, Germany as well as Deputy Editor of the journal Laboratory Animals. Her scientific field of interest is the evaluation of severity assessment tools and the reliable assessment of pain in laboratory rodents. She has authored many publications (original articles, reviews, recommendations and book chapters) on the refinement of anesthesia and analgesia protocols to ensure scientific quality and animal welfare in animal-based research. Furthermore, her interests lie also in the non-pharmacological improvement of animal well-being involving refined post-surgical protocols and experimental housing conditions.

    Affiliations and expertise

    Institute for Laboratory Animal Science, University of Zurich, Switzerland

    Jennie Lofgren

    Jennifer Lofgren: is the Global Head of Animal Welfare and Compliance at Novartis as well as an Adjunct Faculty member at the University of Michigan Medical School where she co-founded the Refinement and Enrichment Advancements Laboratory (REAL). She has a DVM and MS from Tufts University and a BA from Wellesley College. She completed a post-doctoral training program at the Massachusetts Institute of Technology and a visiting research fellowship with the Pain and Animal Welfare Science group at Newcastle University in the UK. She is a diplomate of the American College of Laboratory Animal Medicine (ACLAM). She is the chair of the Non-Human Pain Special Interest Group within the International Association for the Study of Pain (IASP). She has received several grants through Grants for Laboratory Animal Science (GLAS) and ACLAM Foundation and published a variety of peer-reviewed articles and book chapters in the 3Rs (Reduce, Refine, Replace) areas with particular focus on the effective recognition and alleviation of pain in rodents, the comparative impact of unalleviated pain and analgesia on research outcomes, social housing of rabbits, the value of nesting for mouse health assessments, and refinements to reduce animal numbers.

    Affiliations and expertise

    Global Head of Animal Welfare and Compliance, Novartis; Adjunct Faculty Member, University of Michigan Medical School, MA, USA

    Elizabeth Nunamaker

    Dr. Elizabeth Nunamaker received the PhD degree in Biomedical Engineering in 2006 from University of Michigan, and the DVM degree from Purdue University in 2010. She is also double boarded by the American College of Laboratory Animal Medicine and the American College of Animal Welfare. She has spent the past 10+ years of her career focused on the welfare of laboratory animal species and has numerous publications pertaining to anesthesia and analgesia. Dr. Nunamaker is a member of the Global Animal Welfare and Training team at Charles River Laboratories, serving as the Director of Animal Welfare. She is also currently the President of the North American 3Rs Collaborative where she is focused on spreading rodent refined handling practices and developing a 3Rs certification program for those working in animal research.

    Affiliations and expertise

    Charles River Laboratories, Wilmington, MA, USA

    Daniel Pang

    Daniel Pang: is an Associate Professor of veterinary anaesthesiology at the University of Calgary. He received his veterinary degree from the University of Bristol (2000) and went on to complete a residency and MSc in veterinary anaesthesia at the Université de Montréal. He received his doctorate in neuroscience (molecular mechanisms of volatile anaesthetics) from Imperial College, London (2011) and is a Diplomate of the European and American Colleges of Veterinary Anaesthesia and Analgesia. His research interests are in pain assessment and welfare, particularly the applications of pain assessment scales, patient safety and and the concept of enhanced recovery protocols for optimising perioperative care. His research is supported through federal (Natural Sciences and Engineering Research Council of Canada) and private foundation (Fondation J.-Louis Lévesque) funding. He is an editorial board member of Veterinary Anaesthesia and Analgesia and an Associate Editor for the Journal of Small Animal Practice and BMJ Veterinary Record Case Reports.

    Affiliations and expertise

    Associate Professor of Veterinary Anaesthesiology, University of Calgary, Montreal, Canada

info